162. Pemphigoid Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 90 / Drugs : 122 - (DrugBank : 47) / Drug target genes : 34 - Drug target pathways : 144
Pemphigoid and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
162 | Pemphigoid | - |
46 | Malignant rheumatoid arthritis | 26.036 |
96 | Crohn disease | 18.390 |
13 | Multiple sclerosis/Neuromyelitis optica | 18.045 |
50 | Dermatomyositis | 16.705 |
53 | Sjogren syndrome | 16.279 |
51 | Scleroderma | 16.094 |
97 | Ulcerative colitis | 15.795 |
56 | Behcet disease | 15.194 |
49 | Systemic lupus erythematosus | 14.770 |
269 | Pyogenic arthritis | 13.463 |
271 | Ankylosing spondylitis | 13.410 |
41 | Giant cell arteritis | 13.004 |
93 | Primary biliary cholangitis | 12.761 |
107 | Juvenile idiopathic arthritis | 12.650 |
65 | Primary immunodeficiency | 12.641 |
45 | Eosinophilic granulomatosis with Polyangiitis | 12.209 |
40 | Takayasu arteritis | 11.727 |
84 | Sarcoidosis | 11.614 |
11 | Myasthenia gravis | 9.545 |
160 | Congenital ichthyosis | 9.455 |
66 | IgA nephropathy | 9.164 |
60 | Aplastic anemia | 8.626 |
284 | Diamond-Blackfan anemia | 8.529 |
2 | Amyotrophic lateral sclerosis | 8.524 |
6 | Parkinson disease | 8.459 |
228 | Bronchiolitis obliterans | 8.225 |
283 | Acquired pure red cell aplasia | 8.148 |
42 | Polyarteritis nodosa | 7.888 |
226 | Interstitial cystitis with Hunners ulcer | 7.703 |
224 | Purpura nephritis | 7.677 |
44 | Wegener granulomatosis | 7.508 |
62 | Paroxysmal nocturnal hemoglobinuria | 7.508 |
285 | Fanconi anemia | 7.418 |
55 | Relapsing polychondritis | 7.364 |
299 | Cystic fibrosis | 7.115 |
85 | Idiopathic interstitial pneumonia | 7.079 |
164 | Oculocutaneous albinism | 7.059 |
222 | Primary nephrotic syndrome | 6.800 |
28 | Systemic amyloidosis | 6.673 |
19 | Lysosomal storage disease | 6.606 |
63 | Idiopathic thrombocytopenic purpura | 6.400 |
286 | Hereditary sideroblastic anemia | 6.311 |
35 | Pemphigus | 6.198 |
151 | Rasmussen encephalitis | 6.000 |
61 | Autoimmune hemolytic anemia | 5.818 |
95 | Autoimmune hepatitis | 5.555 |
43 | Microscopic polyangiitis | 5.403 |
20 | Adrenoleukodystrophy | 5.132 |
302 | Leber hereditary optic neuropathy | 5.000 |
39 | Toxic epidermal necrolysis | 4.994 |
326 | Osteopetrosis | 4.970 |
234 | Peroxisomal disease (except Adrenoleukodystrophy) | 4.702 |
36 | Epidermolysis bullosa | 4.453 |
38 | Stevens-Johnson syndrome | 4.059 |
64 | Thrombotic thrombocytopenic purpura | 3.898 |
26 | HTLV-1-associated myelopathy | 3.215 |
274 | Osteogenesis Imperfecta | 3.195 |
227 | Osler disease | 3.163 |
300 | IgG4-related disease | 3.055 |
265 | Lipodystrophy | 2.970 |
270 | Chronic recurrent multifocal osteomyelitis | 2.828 |
94 | Primary sclerosing cholangitis | 2.641 |
158 | Tuberous sclerosis | 2.588 |
37 | Generalised pustular psoriasis | 2.564 |
34 | Neurofibromatosis | 2.497 |
98 | Eosinophilic gastrointestinal disease | 2.426 |
87 | Pulmonary veno-occlusive disease | 2.318 |
58 | Hypertrophic cardiomyopathy | 2.289 |
113 | Muscular dystrophy | 2.139 |
268 | Nakajo-Nishimura syndrome | 2.000 |
325 | Hereditary autoinflammatory syndrome | 2.000 |
8 | Huntington disease | 1.944 |
90 | Retinitis pigmentosa | 1.692 |
88 | Chronic thromboembolic pulmonary hypertension | 1.566 |
256 | Muscle glycogenosis | 1.442 |
331 | Idiopathic multicentric castleman disease | 1.442 |
86 | Pulmonary arterial hypertension | 1.385 |
172 | Hypophosphatasia | 1.374 |
246 | Methylmalonic acidemia | 1.312 |
78 | Hypopituitarism | 1.240 |
236 | Pseudohypoparathyroidism | 1.188 |
235 | Hypoparathyroidism | 1.061 |
89 | Lymphangioleiomyomatosis | 1.006 |
52 | Mixed connective tissue disease | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |